Primary |
Type 2 Diabetes Mellitus |
42.0% |
Diabetes Mellitus |
27.6% |
Hypertension |
13.9% |
Product Used For Unknown Indication |
2.2% |
Dyslipidaemia |
2.1% |
Hypercholesterolaemia |
1.5% |
Blood Glucose |
1.1% |
Insulin-requiring Type 2 Diabetes Mellitus |
1.1% |
Coronary Artery Disease |
1.0% |
Hyperlipidaemia |
0.9% |
Hypothyroidism |
0.9% |
Atrial Fibrillation |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
Depression |
0.7% |
Pain |
0.6% |
Type 1 Diabetes Mellitus |
0.6% |
Cardiac Failure |
0.5% |
Benign Prostatic Hyperplasia |
0.5% |
Blood Cholesterol Increased |
0.5% |
Blood Glucose Increased |
0.5% |
|
Pancreatitis |
25.9% |
Pancreatic Carcinoma |
6.8% |
Vomiting |
6.1% |
Weight Decreased |
6.0% |
Pancreatitis Acute |
5.4% |
Diarrhoea |
5.2% |
Renal Failure |
5.2% |
Renal Failure Acute |
4.7% |
Drug Ineffective |
3.7% |
Hypoglycaemia |
3.7% |
Lipase Increased |
3.4% |
Nausea |
3.0% |
Wrong Technique In Drug Usage Process |
3.0% |
Death |
2.8% |
Myocardial Infarction |
2.8% |
Inappropriate Schedule Of Drug Administration |
2.6% |
Lactic Acidosis |
2.6% |
Rash |
2.6% |
Oedema Peripheral |
2.3% |
Pruritus |
2.3% |
|
Secondary |
Type 2 Diabetes Mellitus |
33.5% |
Diabetes Mellitus |
16.5% |
Hypertension |
16.0% |
Product Used For Unknown Indication |
9.0% |
Hyperlipidaemia |
2.8% |
Hypersensitivity |
2.6% |
Gastrooesophageal Reflux Disease |
2.6% |
Asthma |
1.8% |
Blood Glucose |
1.8% |
Drug Use For Unknown Indication |
1.6% |
Depression |
1.5% |
Hypertriglyceridaemia |
1.5% |
Hyperuricaemia |
1.4% |
Hypercholesterolaemia |
1.3% |
Migraine |
1.1% |
Pain |
1.1% |
Chest Pain |
1.0% |
Dyslipidaemia |
1.0% |
Anxiety |
0.9% |
Diabetic Neuropathy |
0.9% |
|
Pancreatitis |
17.1% |
Pancreatic Carcinoma |
9.7% |
Liver Injury |
8.3% |
Renal Failure Acute |
7.4% |
Wrong Technique In Drug Usage Process |
6.5% |
Weight Decreased |
5.1% |
Vomiting |
4.6% |
Overdose |
4.2% |
Blood Glucose Increased |
3.7% |
Memory Impairment |
3.7% |
Nausea |
3.7% |
Hypoglycaemia |
3.2% |
Inappropriate Schedule Of Drug Administration |
3.2% |
Pancreatitis Acute |
3.2% |
Diarrhoea |
2.8% |
Drug Hypersensitivity |
2.8% |
Incorrect Dose Administered |
2.8% |
Lipase Increased |
2.8% |
Urinary Tract Infection |
2.8% |
Headache |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
38.1% |
Diabetes Mellitus |
12.5% |
Drug Use For Unknown Indication |
11.1% |
Hypertension |
9.2% |
Type 2 Diabetes Mellitus |
7.8% |
Blood Cholesterol Increased |
3.7% |
Rheumatoid Arthritis |
1.9% |
Atrial Fibrillation |
1.8% |
Depression |
1.7% |
Blood Triglycerides Increased |
1.5% |
Asthma |
1.4% |
Pain |
1.3% |
Prophylaxis |
1.2% |
Blood Pressure |
1.1% |
Gastrooesophageal Reflux Disease |
1.0% |
High Density Lipoprotein Decreased |
1.0% |
Cardiac Disorder |
0.9% |
Hepatitis C |
0.9% |
Hypothyroidism |
0.9% |
Psoriasis |
0.9% |
|
Flushing |
10.6% |
Blood Glucose Increased |
9.4% |
Pruritus |
8.4% |
Vomiting |
8.1% |
Weight Decreased |
5.8% |
Drug Ineffective |
5.6% |
Nausea |
5.6% |
Weight Increased |
5.4% |
Diarrhoea |
4.6% |
Paraesthesia |
4.0% |
Myocardial Infarction |
3.8% |
Pain |
3.6% |
Dyspnoea |
3.5% |
Pain In Extremity |
3.5% |
Urticaria |
3.5% |
Urinary Tract Infection |
3.3% |
Injection Site Pain |
3.1% |
Skin Burning Sensation |
3.1% |
Pancreatitis |
2.7% |
Rash |
2.7% |
|
Interacting |
Product Used For Unknown Indication |
20.0% |
Diabetes Mellitus |
12.0% |
Essential Hypertension |
12.0% |
Hyperlipidaemia |
8.0% |
Type 2 Diabetes Mellitus |
8.0% |
Abdominal Discomfort |
4.0% |
Asthenia |
4.0% |
Blood Cholesterol Increased |
4.0% |
Depression |
4.0% |
Diarrhoea |
4.0% |
Fluid Retention |
4.0% |
Gastrooesophageal Reflux Disease |
4.0% |
Hypertension |
4.0% |
Myocardial Ischaemia |
4.0% |
Nephrolithiasis |
4.0% |
|
Drug Interaction |
22.2% |
Renal Disorder |
22.2% |
Trabeculectomy |
22.2% |
Hyperhidrosis |
11.1% |
Personality Change |
11.1% |
Speech Disorder |
11.1% |
|